公开(公告)号：US08124496B2

公开(公告)日：2012-02-28

申请号：US12953384

申请日：2010-11-23

申请人： Ping-Sheng Su ,  Dou-Feng Wu ,  Wei Zhang ,  Da-Wei Xing

发明人： Ping-Sheng Su ,  Dou-Feng Wu ,  Wei Zhang ,  Da-Wei Xing

IPC分类号： H01R13/58

CPC分类号： H01R13/7175 ,  H01R13/6658 ,  H01R13/7172 ,  H01R24/20

摘要： A cable connector assembly (100) comprises a mating member (3) assembled with a plurality of contacts (33, 34), a printed circuit board (2), a cable (7) having a plurality of wires (71) and a strain relief portion (72), and a light pipe located (4) between the printed circuit board and the strain relief portion. The printed circuit board is attached with a LED (24), and the LED is electrically connected with the contacts. The printed circuit board defines a front surface, a rear surface and a cutout (23) extending through the front surface and the rear surface along a mating direction, and the LED is disposed behind the rear surface of the printed circuit board, the wires are extending through the cutout of the printed circuit board and soldered to the contacts in front of the printed circuit board.

摘要翻译： 电缆连接器组件（100）包括组装有多个触头（33,34）的配合构件（3），印刷电路板（2），具有多根电线（71）的电缆（7） 释放部分（72）和位于印刷电路板和应变消除部分之间的光管（4）。 印刷电路板附有LED（24），LED与触点电连接。 印刷电路板沿着配合方向限定前表面，后表面和延伸穿过前表面和后表面的切口（23），并且LED布置在印刷电路板的后表面之后，导线是 延伸穿过印刷电路板的切口并焊接到印刷电路板前面的触点。

公开(公告)号：US08117436B2

公开(公告)日：2012-02-14

申请号：US12297638

申请日：2007-04-19

申请人： Wei Zhang ,  Niraj K. Jha ,  Li Shang

发明人： Wei Zhang ,  Niraj K. Jha ,  Li Shang

IPC分类号： G06F1/24

CPC分类号： G11C11/40615 ,  H01L51/0052 ,  H03K19/17752 ,  H03K19/17776 ,  H03K19/1778

摘要： A hybrid nanotube, high-performance, dynamically reconfigurable architecture, NATURE, is provided, and a design optimization flow method and system, NanoMap. A run-time reconfigurable architecture is provided by associating a non-volatile universal memory to each logic element to enable cycle-by-cycle reconfiguration and logic folding, while remaining CMOS compatible. Through logic folding, significant logic density improvement and flexibility in performing area-delay tradeoffs are possible. NanoMap incorporates temporal logic folding during the logic mapping, temporal clustering and placement steps. NanoMap provides for automatic selection of a best folding level, and uses force-direct scheduling to balance resources across folding stages. Mapping can thereby target various optimization objectives and user constraints. A high-density, high-speed carbon nanotube RAM can be implemented as the universal memory, allowing on-chip multi-context configuration storage, enabling fine-grain temporal logic folding, and providing a significant increase in relative logic density.

摘要翻译： 提供混合纳米管，高性能，动态可重构架构，NATURE，以及NanoMap的设计优化流程方法和系统。 通过将非易失性通用存储器与每个逻辑元件相关联来提供运行时可重构架构，以实现逐周期重新配置和逻辑折叠，同时保持CMOS兼容性。 通过逻辑折叠，可以实现显着的逻辑密度改进和执行区域延迟权衡的灵活性。 NanoMap在逻辑映射，时间聚类和放置步骤期间包含时间逻辑折叠。 NanoMap提供自动选择最佳折叠级别，并使用强制直接调度来平衡折叠阶段的资源。 因此，映射可以针对各种优化目标和用户约束。 高密度高速碳纳米管RAM可以实现为通用存储器，允许片上多上下文配置存储，实现细粒度时间逻辑折叠，并提供相对逻辑密度的显着增加。

公开(公告)号：US08105828B2

公开(公告)日：2012-01-31

申请号：US12843536

申请日：2010-07-26

申请人： Albert J. Owen, III ,  Ismael J. Hidalgo ,  Jibin Li ,  Wei Zhang

发明人： Albert J. Owen, III ,  Ismael J. Hidalgo ,  Jibin Li ,  Wei Zhang

IPC分类号： C07H21/02 ,  C07H21/04 ,  C12N15/00 ,  C12Q1/68

CPC分类号： C12N15/1138 ,  C12N15/111 ,  C12N2310/14 ,  C12N2320/12 ,  G01N33/502

摘要： Nucleic acids and vectors for interfering with the expression of membrane efflux transport proteins in cells that express such proteins are provided. Also provided are cells and cell lines comprising such nucleic acids and vectors. Methods for screening chemicals and biomolecules for gastrointestinal absorption in animals, and kits for practicing such methods are also provided.

摘要翻译： 提供了用于干扰表达这种蛋白质的细胞中膜外排转运蛋白表达的核酸和载体。 还提供了包含这种核酸和载体的细胞和细胞系。 还提供了用于筛选动物中用于胃肠道吸收的化学物质和生物分子的方法，以及用于实践这些方法的试剂盒。

公开(公告)号：US20120007603A1

公开(公告)日：2012-01-12

申请号：US12886261

申请日：2010-09-20

申请人： Wei ZHANG

发明人： Wei ZHANG

IPC分类号： G01N27/416

CPC分类号： H01M10/4207 ,  G01R31/3658

摘要： A circuit used for determining a cell number of several battery cells. The circuit includes a detection block and a controller, and operates in a first detection mode and a second detection mode. The detection block is coupled to each of the battery cells. In the first detection mode, the detection block provides a terminal voltage signal indicative of a terminal voltage of a battery cell. In the second detection mode, the detection block provides a cell voltage signal indicative of a cell voltage of the battery cell. The controller compares the terminal voltage signal with a first threshold in the first detection mode and compares the cell voltage signal with a second threshold in the second detection mode, and provides a cell count signal indicative of the cell number based on the terminal voltage signal and the cell voltage signal.

摘要翻译： 用于确定几个电池单元的单元数的电路。 电路包括检测块和控制器，并且在第一检测模式和第二检测模式下操作。 检测块耦合到每个电池单元。 在第一检测模式中，检测块提供指示电池单元的端子电压的端子电压信号。 在第二检测模式中，检测块提供指示电池单元的单元电压的单元电压信号。 所述控制器将所述端子电压信号与所述第一检测模式中的第一阈值进行比较，并将所述单元电压信号与所述第二检测模式中的第二阈值进行比较，并且基于所述端子电压信号提供表示所述单元号的单元计数信号，以及 电池电压信号。

公开(公告)号：US08094903B2

公开(公告)日：2012-01-10

申请号：US12157837

申请日：2008-06-13

申请人： Ying Zhu ,  Wei Zhang ,  Adrian Barbu ,  Simone Prummer ,  Martin Ostermeier ,  Dorin Comaniciu

发明人： Ying Zhu ,  Wei Zhang ,  Adrian Barbu ,  Simone Prummer ,  Martin Ostermeier ,  Dorin Comaniciu

IPC分类号： G06K9/03

CPC分类号： A61B6/504 ,  A61B6/481 ,  G06T5/50 ,  G06T7/215 ,  G06T7/30 ,  G06T2207/10016 ,  G06T2207/10121 ,  G06T2207/30048 ,  G06T2207/30101

摘要： A method and system for extracting coronary vessels fluoroscopic image sequences using coronary digital subtraction angiography (DSA) are disclosed. A set of mask images of a coronary region is received, and a sequence of contrast images for the coronary region is received. For each contrast image, vessel regions are detected in the contrast image using learning-based vessel segment detection and a background region of the contrast image is determined based on the detected vessel regions. Background motion is estimated between one of the mask images and the background region of the contrast image, and the mask image is warped based on the estimated background motion to generate an estimated background layer. The estimated background layer is subtracted from the contrast image to extract a coronary vessel layer for the contrast image.

摘要翻译： 公开了使用冠状动脉数字减影血管造影（DSA）提取冠脉血管荧光镜图像序列的方法和系统。 接收冠状动脉区域的一组掩模图像，并且接收冠状动脉区域的对比度图像序列。 对于每个对比图像，使用基于学习的血管段检测在对比图像中检测血管区域，并且基于检测到的血管区域确定造影剂图像的背景区域。 在掩模图像之一和对比度图像的背景区域之间估计背景运动，并且基于所估计的背景运动来对掩模图像进行翘曲以生成估计的背景层。 从对比图像中减去估计的背景层，以提取对比度图像的冠状血管层。

公开(公告)号：US20110312368A1

公开(公告)日：2011-12-22

申请号：US13223120

申请日：2011-08-31

申请人： Karama Hamdi ,  Wei Zhang ,  Khaled Ben Letaief

发明人： Karama Hamdi ,  Wei Zhang ,  Khaled Ben Letaief

IPC分类号： H04W52/04

CPC分类号： H04W52/26 ,  H04W16/14 ,  H04W52/242 ,  H04W52/243 ,  H04W52/246 ,  H04W52/265 ,  H04W52/283 ,  H04W64/00

摘要： For cognitive radio systems, the transmit power of a cognitive radio device is controlled so that the cognitive, unlicensed radio device does not interfere with the use of a shared spectrum by a primary, licensed device. Controlling the transmit power includes determining a distance, or a function of the distance, between a primary transmitter of the primary device and the cognitive radio device based on sensing information from a spectrum sensing process. The maximum transmit power of the cognitive radio device is then dynamically controlled based on the distance, or the function of the distance, while considering a worst case scenario of an underlying cognitive radio model, to guarantee a quality of service requirement of the primary device.

摘要翻译： 对于认知无线电系统，认知无线电设备的发射功率被控制，使得认知的，未许可的无线电设备不会干扰主要许可设备使用共享频谱。 控制发射功率包括基于来自频谱感测过程的感测信息确定主设备的主发射机与认知无线电设备之间的距离或距离的函数。 然后在考虑基础认知无线电模型的最坏情况的情况下，基于距离的距离或距离的函数来动态地控制认知无线电设备的最大发射功率，以保证主设备的服务质量要求。

公开(公告)号：US08081403B1

公开(公告)日：2011-12-20

申请号：US12170619

申请日：2008-07-10

申请人： Benjamin Chen ,  Hongping Yuan ,  Danning Yang ,  Wei Zhang ,  Hugh C. Hiner ,  Lei Wang ,  Yingjian Chen ,  Brant Nease

发明人： Benjamin Chen ,  Hongping Yuan ,  Danning Yang ,  Wei Zhang ,  Hugh C. Hiner ,  Lei Wang ,  Yingjian Chen ,  Brant Nease

IPC分类号： G11B5/39

CPC分类号： H01L43/12 ,  B82Y10/00 ,  B82Y25/00 ,  G11B5/3906 ,  G11B5/3909

摘要： A magnetic element includes a pinned layer, a nonferromagnetic spacer layer, and a free layer. The nonferromagnetic spacer layer resides between the pinned layer and the free layer. The free layer has a track width of not more than 0.08 micron.

摘要翻译： 磁性元件包括钉扎层，非铁磁隔离层和自由层。 非铁磁间隔层位于被钉扎层和自由层之间。 自由层的轨道宽度不大于0.08微米。

公开(公告)号：US08075157B2

公开(公告)日：2011-12-13

申请号：US12604409

申请日：2009-10-23

申请人： Hai-Wei Zhang ,  Jia-Chuan Lv

发明人： Hai-Wei Zhang ,  Jia-Chuan Lv

IPC分类号： F21V21/00

CPC分类号： H01L33/58 ,  G02B19/0028 ,  G02B19/0061 ,  G02B19/0071 ,  G02B27/0927 ,  G02B27/0955 ,  H01L25/0753 ,  H01L2924/0002 ,  H01L2924/00

摘要： An LED module includes an LED having an optic axis and a lens fixed over the LED for refracting light emitted by the LED. The lens has a same cross section along a front-to-rear direction thereof. The lens has an inner incidence surface facing the LED and an outer emission surface. The inner incidence surface is concave toward the emission surface. The emission surface has a middle part around the optic axis of the LED concave toward the incidence surface, and two convex lateral parts off the optic axis of the LED. A peak intensity for the light generated by the LED and penetrating through the lens occurs within the convex lateral parts of the emission surface.

摘要翻译： LED模块包括具有光轴的LED和固定在LED上的透镜，用于折射由LED发射的光。 透镜沿其​​前后方向具有相同的横截面。 透镜具有面向LED的内部入射表面和外部发射表面。 内部入射表面朝向发射表面凹陷。 发射表面具有围绕LED的光轴的中间部分朝向入射表面凹入，并且两个凸出的侧向部分离开LED的光轴。 由LED产生的并穿透透镜的光的峰值强度发生在发射表面的凸侧面部分内。

公开(公告)号：US08058665B2

公开(公告)日：2011-11-15

申请号：US12566696

申请日：2009-09-25

申请人： Zhong-Qing Wang ,  Hai-Wei Zhang

发明人： Zhong-Qing Wang ,  Hai-Wei Zhang

IPC分类号： H01L33/00

CPC分类号： F21V5/04 ,  F21K9/69 ,  F21V5/008 ,  F21V7/0091 ,  F21V13/04 ,  F21Y2115/10 ,  G02B19/0028 ,  G02B19/0061 ,  H01L33/58 ,  H01L33/60

摘要： An LED module includes an LED and a lens located over and enclosing the LED. The lens includes a surface of incidence facing the LED for an incidence of light emitted from the LED and a surface of emission for an emission of the light out of the LED module. The surface of incidence has a convex spherical surface, and the surface of emission has a concave spherical surface corresponding to the convex spherical surface. The convex spherical surface refracts the light incident thereon to redirect the light to the concave spherical surface. The concave spherical surface spreads the light into a wide and uniform beam. The surface of emission further has a first cylinder extending downwardly from an outer edge of the concave spherical surface. A totally reflective coincoid extends downwards from the first cylinder to a bottom of the LED module.

摘要翻译： LED模块包括LED和位于LED周围并包围LED的透镜。 透镜包括面对LED的入射表面，用于从LED发射的光的入射和用于从LED模块发出光的发射表面。 入射面具有凸球面，发射面具有对应于凸球面的凹球面。 凸球面折射入射到其上的光以将光重定向到凹球面。 凹球面将光扩展成宽而均匀的光束。 发射表面还具有从凹形球形表面的外边缘向下延伸的第一圆柱体。 一个完全反射的硬币从第一个汽缸向下延伸到LED模块的底部。

公开(公告)号：US20110269812A1

公开(公告)日：2011-11-03

申请号：US13124112

申请日：2009-10-14

申请人： Mei Lin Go ,  Han Kiat Ho ,  Wei Zhang

发明人： Mei Lin Go ,  Han Kiat Ho ,  Wei Zhang

IPC分类号： A61K31/404 ,  A61P35/00 ,  C12Q1/18 ,  C07D209/34 ,  C12N9/99

CPC分类号： C07D209/34

摘要： The present invention relates generally to organic chemistry, biochemistry, pharmacology and medicine. More particularly, it relates to 3-benzylidene-indolin-2-one derivatives and their physiologically acceptable salts and prodrugs which modulate the activity of protein kinases (“PKs”), especially protein tyrosine kinase, and, therefore, are expected to exhibit a salutary effect against disorders related to abnormal PK activity. The present invention is further directed to methods of using of these compounds, alone or in combination with other therapeutic agents, for the alleviation, prevention and/or treatment of protein kinase-mediated diseases and disorders, such as cancer.

摘要翻译： 本发明一般涉及有机化学，生物化学，药理学和药物。 更具体地说，本发明涉及3-亚苄基 - 二氢吲哚-2-酮衍生物及其生理上可接受的盐和前体药物，其调节蛋白激酶（“PK”）的活性，特别是蛋白质酪氨酸激酶，因此预期其表现出 对与PK异常活动相关的疾病有益的效果。 本发明进一步涉及使用这些化合物单独或与其它治疗剂组合用于缓解，预防和/或治疗蛋白激酶介导的疾病和病症如癌症的方法。